AstraZeneca wins Crestor ruling

17-12-2012

AstraZeneca wins Crestor ruling

UK pharmaceutical company AstraZeneca has won an appeal court ruling to block the sale of generic versions of its cholesterol medicine Crestor in the US until July 2016.


AstraZeneca, Crestor, ruling, generics, inequitable conduct

WIPR